ABSTRACT
Hypoxia is known to promote vasodilation of coronary vessels through several mediators including cardiac-derived adenosine and endothelium-derived prostanoids and nitric oxide. To date, the impact of endogenous glycogen depletion in vascular smooth muscle and the resultant alterations in cellular energy state (e.g., AMP-activated protein kinase, AMPK) on the contractile response to G protein-coupled receptor agonists (e.g., serotonin, 5-HT) has not yet been studied. In the present study, ex vivo exposure of endothelium-denuded human saphenous vein rings to hypoxic and glucose-deprived conditions during KCl-induced contractions for 30 min resulted in a marked depletion of endogenous glycogen by â¼80% (from â¼1.78 µmol/g under normoxia to â¼0.36 µmol/g under hypoxia). Importantly, glycogen-depleted HSV rings, which were maintained under hypoxia/reoxygenation and glucose-deprived conditions, exhibited significant increases in basal AMPK phosphorylation (â¼6-fold ↑) and 5-HT-induced AMPK phosphorylation (â¼19-fold ↑) with an accompanying suppression of 5-HT-induced maximal contractile response (â¼68% ↓), compared with respective controls. Exposure of glycogen-depleted HSV rings to exogenous D-glucose, but not the inactive glucose analogs, prevented the exaggerated increase in 5-HT-induced AMPK phosphorylation and restored 5-HT-induced maximal contractile response. In addition, the ability of exogenous D-glucose to rescue cellular stress and impaired contractile function occurred through GLUT1-mediated but insulin/GLUT4-independent mechanisms. Together, the present findings from clinically-relevant human saphenous vein suggest that the loss of endogenous glycogen in vascular smooth muscle and the resultant accentuation of AMPK phosphorylation by GPCR agonists may constitute a yet another mechanism of metabolic vasodilation of coronary vessels in ischemic heart disease.
Subject(s)
AMP-Activated Protein Kinases/metabolism , Allostasis , Glucose/metabolism , Glycogen/metabolism , Muscle, Smooth, Vascular/metabolism , Myocardial Ischemia/metabolism , Saphenous Vein/metabolism , Aged , Animals , Aorta, Thoracic/metabolism , Biological Transport , Cell Hypoxia , Enzyme Activation , Female , Glucose/analogs & derivatives , Glycogenolysis , Humans , In Vitro Techniques , Male , Middle Aged , Muscle, Smooth, Vascular/enzymology , Myocardial Ischemia/enzymology , Oxidative Stress , Phosphorylation , Protein Processing, Post-Translational , Rats, Wistar , Saphenous Vein/enzymology , VasoconstrictionABSTRACT
Myeloid-derived suppressor cells (MDSCs) are heterogeneous immature myeloid cells that accumulate in response to tumor progression. Compelling data from mouse models and human cancer patients showed that tumor-induced inflammatory mediators induce MDSC differentiation. However, the mechanisms underlying MDSC persistence is largely unknown. Here, we demonstrated that tumor-induced MDSCs exhibit significantly decreased spontaneous apoptosis as compared with myeloid cells with the same phenotypes from tumor-free mice. Consistent with the decreased apoptosis, cell surface Fas receptor decreased significantly in tumor-induced MDSCs. Screening for changes of key apoptosis mediators downstream the Fas receptor revealed that expression levels of IRF8 and Bax are diminished, whereas expression of Bcl-xL is increased in tumor-induced MDSCs. We further determined that IRF8 binds directly to Bax and Bcl-x promoter in primary myeloid cells in vivo, and IRF8-deficient MDSC-like cells also exhibit increased Bcl-xL and decreased Bax expression. Analysis of CD69 and CD25 levels revealed that cytotoxic T lymphocytes (CTLs) are partially activated in tumor-bearing hosts. Strikingly, FasL but not perforin and granzymes were selectively activated in CTLs in the tumor-bearing host. ABT-737 significantly increased the sensitivity of MDSCs to Fas-mediated apoptosis in vitro. More importantly, ABT-737 therapy increased MDSC spontaneous apoptosis and decreased MDSC accumulation in tumor-bearing mice. Our data thus determined that MDSCs use down-regulation of IRF8 to alter Bax and Bcl-xL expression to deregulate the Fas-mediated apoptosis pathway to evade elimination by host CTLs. Therefore, targeting Bcl-xL is potentially effective in suppression of MDSC persistence in cancer therapy.
Subject(s)
Apoptosis , Drug Resistance, Bacterial/genetics , Gene Expression Regulation, Neoplastic , Myeloid Cells/cytology , Neoplasms/metabolism , bcl-X Protein/metabolism , Animals , CD8-Positive T-Lymphocytes/cytology , Caspase 8/metabolism , Humans , Interferon Regulatory Factors/metabolism , Mice , Mice, Inbred BALB C , bcl-2-Associated X Protein/metabolism , fas Receptor/metabolismABSTRACT
BACKGROUND: The authors examine fatigue culture among surgical residents and faculty members and whether it squares with recent, fatigue-focused Accreditation Council for Graduate Medical Education (ACGME) policies and educational initiatives. METHOD: Field observations of an academic general surgery program were supplemented with interviews (52 residents and 58 faculty members) conducted as part of a study of 15 general surgery programs. Field notes and interviews were analyzed for main themes. RESULTS: Most believe that fatigue surfaces after 24 hours of work and has minor consequences. Surgeons believe that residents can learn to manage fatigue and that surgical practice requires that capacity. Proper training implies that residents experience fatigue, learn to perform capably and confidently while fatigued, and recognize their limits. CONCLUSIONS: Encountering and learning to manage fatigue are seen as educational necessities by surgeons, a view that runs counter to ACGME initiatives, requires reconsideration, and demands that attention be directed to professional and organizational practices that sustain fatigue culture.